glp-1 semaglutide for weight loss Benefits of GLP-1 Drugs from the Gray

The FDA is reconsidering its decision to remove Eli Lillys drugs, Zepbound and Mounjaro, from the shortage list, temporarily allowing compounding facilities to continue producing alternative versions

When Should GLP-1 Agonists Be Avoided

When integrated into a physician-supervised medical weight loss program, these medications address why your body resisted weight loss in the first place

Glucagon-like peptide-1: modulator of -cell dysfunction and death

Conclusion and Future Perspectives GLP-1RAs represent a paradigm shift in obesity and metabolic disease treatment with expanding indications and growing global use

Source Data Extended Data Figs